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Abstract Three distinct steps underlie immunosuppression by is prevented. The significant finding of this study is that the 
tumor gangliosides: (i) their shedding by the tumor cell, (ii) shed gangliosides, detected at a concentrat ion significantly 
binding to target leukocytes in the tumor microenvironment, and lower than that routinely used in ganglioside binding studies 
(iii) action upon the target ceil. While shedding is well [7], were incorporated into the membrane of the target cells, 
documented, cell to cell transfer of shed gangliosides is not. To and that this binding occurred to a degree which is likely to be 
address this, we employed a dual chamber culture system. In this physiologically relevant. 
system, metabolically radiolabeled lymphoma cells shed gang- 
liosides into the conditioned medium of the contralateral 2. Experimental 
chamber, which contained normal fibroblasts as the target cell. 
The shed lymphoma cell gangliosides bound avidly to the target 2.1. Cell lines 
fibroblasts in a trypsin-resistant manner (1-2 x 106 and 7x  106 YAC-1 murine lymphoma cells were cultured in RPMI 1640 sup- 
molecules/fibroblast in 24 and 48 h). Significantly higher than plemented with 10% heat-inactivated fetal calf serum (FCS), 2 mM 
binding rates of purified lymphoma gangliosides added exoge- glutamine, and 100 units/ml penicillin and streptomycin. Normal hu- 
nously, these binding rates in a system which models the in vivo man fibroblasts (line 42sk, ATCC), the target cells for ganglioside 
microenvironment suggest hat cell to cell ganglioside transfer is binding, were maintained in EMEM containing the same supplements 
a highly efficient process, and used between passages 4 and 12. 
Key words: Ganglioside; Ganglioside shedding; Ganglioside 2.2. Metabolic radiolabeling of cellular gangliosides 
transfer; Intercellular signaling YAC-1 lymphoma cells were metabolically radiolabeled by culture 
for 48 h in complete RPMI 1640 medium containing 10 ktCi each of D- 
[1J4C]glucosamine hydrochloride (specific activity 52.6 mCi/mmol) 
and D-[1-14C]galactose (56.5 mCi/mmol; NEN). The cells were then 
1. Introduction washed six times by centrifugation i complete medium. Following 
the final wash, the cells were resuspended in EMEM at 3.5x106 cells/ 
ml. Cell viability, assessed by trypan blue exclusion, was greater than 
The shedding of endogenous gangliosides by tumor cells is a 98%. Human flbroblasts were cultured to pre-confluency, radiolabeled 
well-recognized process [1-4], and occurs at a rapid rate, i.e. for 48 h as above, washed six times with phosphate-buffered saline 
up to 0.5% of the membrane ganglioside content per hour  [5]. (PBS), and then harvested by trypsinization. 
Less is known about the interaction of exogenous ganglioside 
molecules with cells. When highly purified gangliosides are 2.3. Ganglioside purification and autoradiography 
added to cells in vitro, the ceramide moiety of the ganglioside Radiolabeled gangliosides were isolated from lyophilized cell pellets 
molecule can intercalate into the membrane bilayer in a tryp- and conditioned medium, with 10 nmol purified human brain gang- 
liosides added as a cold carrier, using previously described methods 
sin-resistant manner  [6,7]. This is observed either when puri- [11]. The ganglioside-associated radioactivity was quantified by [3-scin- 
fled exogenous gangliosides, which exist in micellar form or as tillation counting, and confirmed by high-performance thin-layer 
free molecular species, are used [8], or when gangliosides are chromatography (HPTLC) autoradiography [5]. Purified 14C-labeled 
incorporated in artificial membrane systems, such liposomes gangliosides were quantified by a modified resorcinol method [12] to 
[9]. Both approaches have shown that gangliosides can be determine specific activity. 
stably bound by target cells, but neither approach can address 
the question of whether the in vivo process of tumor cell 2.4. Co-incubation studies 
42sk fibroblasts were cultured in 6-well plates (Costar) and grown 
ganglioside shedding can lead to suppression of the cellular to confluence. At the beginning of the experiment, the culture medium 
immune response [10]. One aspect of this problem is to deter- was removed from four plates and 2.0 ml fresh medium was added to 
mine whether immunosuppressive gangliosides, as shed from each of 24 wells. Upper chamber inserts containing a polycarbonate 
tumor ceils, b ind to target cells in the tumor microenviron- membrane with 0.4 ktm pore size (Transwell, Costar) were then in- 
ment. serted in each well, and 7X 106 radiolabeled YAC-1 cells in 2 ml 
medium were added to the top chamber. Following incubation for 
The ideal in vitro condit ions for studying this intercellular 24 h, the upper chamber was removed (and with it the YAC-1 cells) 
exchange of gangliosides would allow for both processes and the upper conditioned medium (CM) collected (1.5 ml/well). The 
(shedding and cellular interaction) to occur as they do in YAC-1 cells were collected by washing the membrane three times with 
vivo. Here, we describe a co-culture system which allows for PBS. The PBS washes were added to the upper CM and the YAC-I 
cells were pelleted by centrifugation at 300 x g. The CM in the lower 
the flow of shed gangliosides from tumor cells to target fibro- chamber (free of lymphoma cells) was removed (2.5 ml/well), and both 
blasts while physical contact between the two cell populat ions the upper and lower CM were centrifuged at 1000 xg  and the super- 
natants retained. Finally, the lower chamber was washed 5 times with 
PBS and the adherent fibroblast monolayer harvested by trypsiniza- 
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2.5. Binding of purified exogenously added gangliosides 
Fibroblasts were cultured in 6-well plates as described in the co- ~i~ 
incubation studies. Metabolically radiolabeled purified YAC-1 gang- U liosides, briefly sonicated in basal medium, were added to each well at o 0 o 0 o 0 0 o 0 o o o~-~ ,er Chamber(~4C-ka~eled VAC-1 cells~ 
a final concentration of 1.0 p.M. Following incubation for 24 and 48 HU I o o o o o o o o o o o o ~ poro,s m,mbr~, (0.4 ,mJ 
h, the unincorporated gangliosides were removed, the fibroblast H ~m,, ~ .__  __  
monolayer harvested, and the binding of the purified gangliosides to Lower chamber (FIbr0blast m0n01ayer~ 
fibroblasts quantified by scintillation counting. ~_=A . . . .  . . . . . . .  ~ J  
Fig. 1. A dual-chamber culture system for the study of cell to cell 
3. Results ganglioside transfer. 
3.1. Dual-chamber culture system 
The dual-chamber culture system is illustrated in Fig. 1. 3.3. Shedding of YAC-1 gangliosides 
When the upper chamber insert is in place, the total volume Shed YAC-1 gangliosides were isolated from the upper and 
in the well is 4.0 ml and the volume in the upper chamber is lower CM from four individual 6-well plates. The ganglioside 
1.5 ml. A 1.0 mm distance separates the fibroblast monolayer concentration in the upper CM was 0.045+0.009 ~M 
in the lower chamber from the YAC-1 cells, seeded in the (mean+ S.E.). In contrast, the ganglioside concentration in 
upper chamber at a concentration of 7 × 106 cells/1.5 ml. 6 the CM on the contralateral side of the membrane from the 
8 × 106 YAC-1 cells (viability >95%) were recovered from the YAC-1 cells was 0.0054 + 0.0004 ~tM. This ten-fold lower con- 
upper chamber at the end of the 24 h co-incubation period, centration of shed YAC-1 gangliosides was in part due to 
Several approaches established that no lymphoma cells were slow diffusion through the membrane, as supported by the 
present on the contralateral side of the membrane, i.e. in the finding that trypan blue (MW--980) placed in the upper cham- 
CM bathing the fibroblast monolayer, in this dual chamber ber of several control wells, even without YAC-1 cells, had 
system. First, visual inspection of the fibroblast monolayer by not fully equilibrated in the lower chamber 24 h later. 
light microscopy showed no contamination by YAC-1 cells, 
which have a strikingly different morphology from that of 3.4. Cell to cell transfer of tumor gangliosides 
normal fibroblasts. Secondly, when the lower CM was centri- The fibroblasts in these studies were cultured to confluence, 
and approximately 1.2 × 107 cells were recovered from 4 plates fuged at 1000 ×g for 10 min to remove large membrane par- 
ticles or intact cells, no pellet was visible, nor did the dpm of at both the 24 and 48 h timepoints. When the total ganglio- 
the CM decrease, indicating that no significant quantity of sides were isolated from the fibroblasts, radiolabeled YAC 
particulate or cell-associated gangliosides, which would have lymphoma gangliosides equivalent to 1.3 1.8× 106 and 
been pelleted, were present. Finally, as a very sensitive meas- 7 × 106 ganglioside molecules per fibroblast, were recovered 
ure of viable cells, we observed no cell proliferation in fresh at 24 and 48 h, respectively (Table 1). As identified by 
cultures which had been seeded with multiple aliquots of the HPTLC autoradiography (Fig. 2, lane 3) the two major 
lower CM removed following the 24 h incubation period. YAC-1 gangliosides accounted for almost all of the total radi- 
olabeled gangliosides isolated from the fibroblast monolayer. 
The relatively faint additional bands of higher mobility iso- 
3.2. Specific activity ofradiolabeled YAC-1 gangliosides lated from the fibroblasts and not seen in the YAC-1 cell 
The recovery of YAC-1 cellular gangliosides ranged from ganglioside pattern (Fig. 2, lane 1) may represent either en- 
13 to 15 nmol lipid-bound sialic acid (LBSA)/10 s cells, in dogenous ganglioside synthesis in the fibroblasts (which may 
good agreement with our previous findings in YAC-1 cells have metabolized trace amounts of radiolabeled precursor 
proliferating in vitro [1,13]. The specific activity of the radi- molecules) or catabolic products of YAC-1 cell gangliosides 
olabeled YAC-1 gangliosides from three separate xperiments metabolized by the target cell. 
ranged between 9800 and 12400 dpm/nmol (Table 1). The 
presence of the two major gangliosides of YAC-1 cells, 3.5. Binding of purified exogenous gangliosides 
GI~lb and GalNAcGMlb [13], was confirmed in the present To place the above results in perspective, we compared 
experiments by HPTLC (Fig. 2, lane 1). In contrast, the pre- them with the binding of highly purified gangliosides added 
dominant ganglioside of human fibroblasts, the target cell, is to the same target cell population. This was done to address 
the more rapidly migrating GM3 [14], which is easily distin- the question of whether 'pure gangliosides' have binding char- 
guishable by HPTLC from that of the lymphoma cell gang- acteristics different from those of gangliosides directly derived, 
liosides (Fig. 2, lane 2). by shedding, from tumor cells without any experimental ma- 
Table 1 
Binding of exogenous YAC-1 lymphoma cell gangliosides to human fibroblasts 
Shed gangliosides Purifed gangliosides 
Time of incubation 24 h 24 h 48 h 24 h 48 h 
(expt 1) (expt 2) (expt 3) (expt 4) (expt 4) 
Specific activity (dpm/nmol) 9800 11 500 12 400 26 700 26 700 
Ganglioside conc. in conditioned medium (p.M) ND ~ 0.005 ~' 0.005 c 1.0 1.0 
Ganglioside binding (molecules/cell) 1.8 × 106 1.3 x 106 7.0 × 106 1.4 × l0 T 3.3 X 107 
aNot determined. 
bMean of four determinations (S.E.<10%). 
R. Olshefski, S. Ladisch/FEBS Letters 386 (1996) 11-14 13 
not readily pass through the membrane separating the two cell 
populations. This is suggested by our findings in the dual- 
chamber system that the ganglioside concentration i the 
upper CM is ten-fold higher than that found in the lower 
CM, and that even trypan blue only slowly equilibrates in 
the two chambers. Therefore, the shed lymphoma cell gang- 
liosides in contact with the fibroblasts will likely be in small 
n vesicles or exist in micelles or as individual molecules. While 
~"M3 the latter two also make up the composition of purified gang- 
t 
liosides when added directly to culture medium, the direct 
comparison of exogenous binding efficiency between shed 
GM 1 . and purified ganglioside molecules uggests that shed mole- 
cules bind to target cells with higher efficiency. 
Other factors which may influence ganglioside binding in- 
clude the presence of serum proteins [17] and lipoproteins 
~'DIa [18,19], present in the tissue culture medium but absent in 
the extravascular tumor microenvironment [20]. These pro- 
GT Ib  teins will compete with the target cell for ganglioside binding 
" in vitro [21], thus reducing effective binding to the target cells. 
Finally, the thousand-fold ower tumor cell density in this in 
vitro system (,-, 106 cells/ml) than in the in vivo microenviron- 
IlBCT 1 2 3 ment (,-~ 109 cells/ml) markedly reduces the quantity of shed 
gangliosides subsequently available for binding to the target 
Fig. 2. Autoradiogram of shed tumor cell gangliosides which have cell. It therefore seems highly likely that the process of trans- 
become tightly bound to target fibroblast cells. RBG, 14C-labeled 
rat brain gangliosides; lane 1, radiolabeled cellular gangliosides of fer we have now documented in vitro is quantitatively much 
YAC-1 lymphoma cells; lane 2, radiolabeled cellular gangliosides of greater in vivo. This is extremely interesting, since even the 
normal human fibroblasts (target cell); lane 3, radiolabeled ganglio- level of binding we show here (approaching I X 107 molecules 
sides recovered from the flbroblast monolayer following 24 h co-in- per cell at 48 h) is, in the case of human peripheral blood 
cubation with ~4C-labeled YAC-1 lymphoma cells. Visualized by ex- 
posure of the HPTLC plate to X-ray film for 6 weeks. Lanes 1, 2, mononuclear cells, a degree of binding associated with 70- 
and 3 contain approximately 1000, 1000, and 400 dpm 14C-ganglio- 90% inhibition of their immunologic responsiveness in an as- 
sides, respectively, say of antigen-induced lymphoproliferation [22]. Such paraly- 
sis of host immune function by tumor gangliosides can be a 
significant factor in tumor escape from host immune destruc- 
nipulation. In this experiment, we measured the binding of tion. 
exogenously added i4C-labeled purified YAC-1 gangliosides 
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